Baicalein Preventive Treatment Confers Optimal Cardioprotection by PTEN/Akt/NO Activation

Jing Li, Wei Tien Chang, Chang Qing Li, Chunpei Lee, Hsien Hao Huang, Chin Wan Hsu, Wen Jone Chen, Xiangdong Zhu, Chong Zhi Wang, Terry L. Vanden Hoek, Zuo Hui Shao

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Baicalein is a flavonoid with excellent oxidant scavenging capability. It has been reported to protect against a variety of oxidative injuries including ischemia/reperfusion (I/R). However, the optimal treatment strategy for I/R injury and the protective mechanisms are not fully understood. In this study we employed an established chick cardiomyocyte model of I/R and investigated the effects of three baicalein treatment strategies on reactive oxygen species (ROS) scavenging, nitric oxide (NO) production and cell viability. The molecular signaling pathways were also explored. Compared to the I/R control (cell death 52.2±2.0%), baicalein preventive treatment (25μM, pretreated for 72h and continued through I/R) conferred the best protection (19.5±3.9%, p<0.001), followed by I/R treatment (treated during I/R) and reperfusion treatment (treated at reperfusion only). Preventive and I/R treatments almost completely abolished ROS generation during both ischemic and reperfusion phases, and increased NO production and Akt phosphorylation. Reperfusion treatment reduced the ROS burst in the early reperfusion phase only, and had no effect on NO production and Akt activation. Further, the phosphorylation of phosphatase and tensin homolog (PTEN), a phosphatase negatively regulating Akt activation, was significantly increased by baicalein preventive treatment and slightly by the I/R treatment. PTEN protein expression was reduced in the same trend accordingly. Baicalein reperfusion treatment had no effects on PTEN phosphorylation and expression. Our results indicate that baicalein preventive treatment confers optimal cardioprotection against I/R injury, and this protection involves effective oxidant scavenging and the activation of PTEN/Akt/NO pathway.

Original languageEnglish
Pages (from-to)987-1001
Number of pages15
JournalAmerican Journal of Chinese Medicine
Volume45
Issue number5
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Phosphoric Monoester Hydrolases
Reperfusion
Nitric Oxide
Ischemia
Reperfusion Injury
Reactive Oxygen Species
Phosphorylation
Oxidants
baicalein
Tensins
Flavonoids
Cardiac Myocytes
Cell Survival
Cell Death

Keywords

  • Akt
  • Baicalein
  • Cardiomyocyte
  • Ischemia/Reperfusion
  • Nitric Oxide
  • PTEN
  • Reactive Oxygen Species

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Baicalein Preventive Treatment Confers Optimal Cardioprotection by PTEN/Akt/NO Activation. / Li, Jing; Chang, Wei Tien; Li, Chang Qing; Lee, Chunpei; Huang, Hsien Hao; Hsu, Chin Wan; Chen, Wen Jone; Zhu, Xiangdong; Wang, Chong Zhi; Vanden Hoek, Terry L.; Shao, Zuo Hui.

In: American Journal of Chinese Medicine, Vol. 45, No. 5, 01.01.2017, p. 987-1001.

Research output: Contribution to journalArticle

Li, J, Chang, WT, Li, CQ, Lee, C, Huang, HH, Hsu, CW, Chen, WJ, Zhu, X, Wang, CZ, Vanden Hoek, TL & Shao, ZH 2017, 'Baicalein Preventive Treatment Confers Optimal Cardioprotection by PTEN/Akt/NO Activation', American Journal of Chinese Medicine, vol. 45, no. 5, pp. 987-1001. https://doi.org/10.1142/S0192415X17500525
Li, Jing ; Chang, Wei Tien ; Li, Chang Qing ; Lee, Chunpei ; Huang, Hsien Hao ; Hsu, Chin Wan ; Chen, Wen Jone ; Zhu, Xiangdong ; Wang, Chong Zhi ; Vanden Hoek, Terry L. ; Shao, Zuo Hui. / Baicalein Preventive Treatment Confers Optimal Cardioprotection by PTEN/Akt/NO Activation. In: American Journal of Chinese Medicine. 2017 ; Vol. 45, No. 5. pp. 987-1001.
@article{fca285f9f86447bc830ef5c8cc6b71f8,
title = "Baicalein Preventive Treatment Confers Optimal Cardioprotection by PTEN/Akt/NO Activation",
abstract = "Baicalein is a flavonoid with excellent oxidant scavenging capability. It has been reported to protect against a variety of oxidative injuries including ischemia/reperfusion (I/R). However, the optimal treatment strategy for I/R injury and the protective mechanisms are not fully understood. In this study we employed an established chick cardiomyocyte model of I/R and investigated the effects of three baicalein treatment strategies on reactive oxygen species (ROS) scavenging, nitric oxide (NO) production and cell viability. The molecular signaling pathways were also explored. Compared to the I/R control (cell death 52.2±2.0{\%}), baicalein preventive treatment (25μM, pretreated for 72h and continued through I/R) conferred the best protection (19.5±3.9{\%}, p<0.001), followed by I/R treatment (treated during I/R) and reperfusion treatment (treated at reperfusion only). Preventive and I/R treatments almost completely abolished ROS generation during both ischemic and reperfusion phases, and increased NO production and Akt phosphorylation. Reperfusion treatment reduced the ROS burst in the early reperfusion phase only, and had no effect on NO production and Akt activation. Further, the phosphorylation of phosphatase and tensin homolog (PTEN), a phosphatase negatively regulating Akt activation, was significantly increased by baicalein preventive treatment and slightly by the I/R treatment. PTEN protein expression was reduced in the same trend accordingly. Baicalein reperfusion treatment had no effects on PTEN phosphorylation and expression. Our results indicate that baicalein preventive treatment confers optimal cardioprotection against I/R injury, and this protection involves effective oxidant scavenging and the activation of PTEN/Akt/NO pathway.",
keywords = "Akt, Baicalein, Cardiomyocyte, Ischemia/Reperfusion, Nitric Oxide, PTEN, Reactive Oxygen Species",
author = "Jing Li and Chang, {Wei Tien} and Li, {Chang Qing} and Chunpei Lee and Huang, {Hsien Hao} and Hsu, {Chin Wan} and Chen, {Wen Jone} and Xiangdong Zhu and Wang, {Chong Zhi} and {Vanden Hoek}, {Terry L.} and Shao, {Zuo Hui}",
year = "2017",
month = "1",
day = "1",
doi = "10.1142/S0192415X17500525",
language = "English",
volume = "45",
pages = "987--1001",
journal = "American Journal of Chinese Medicine",
issn = "0192-415X",
publisher = "World Scientific Publishing Co. Pte Ltd",
number = "5",

}

TY - JOUR

T1 - Baicalein Preventive Treatment Confers Optimal Cardioprotection by PTEN/Akt/NO Activation

AU - Li, Jing

AU - Chang, Wei Tien

AU - Li, Chang Qing

AU - Lee, Chunpei

AU - Huang, Hsien Hao

AU - Hsu, Chin Wan

AU - Chen, Wen Jone

AU - Zhu, Xiangdong

AU - Wang, Chong Zhi

AU - Vanden Hoek, Terry L.

AU - Shao, Zuo Hui

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Baicalein is a flavonoid with excellent oxidant scavenging capability. It has been reported to protect against a variety of oxidative injuries including ischemia/reperfusion (I/R). However, the optimal treatment strategy for I/R injury and the protective mechanisms are not fully understood. In this study we employed an established chick cardiomyocyte model of I/R and investigated the effects of three baicalein treatment strategies on reactive oxygen species (ROS) scavenging, nitric oxide (NO) production and cell viability. The molecular signaling pathways were also explored. Compared to the I/R control (cell death 52.2±2.0%), baicalein preventive treatment (25μM, pretreated for 72h and continued through I/R) conferred the best protection (19.5±3.9%, p<0.001), followed by I/R treatment (treated during I/R) and reperfusion treatment (treated at reperfusion only). Preventive and I/R treatments almost completely abolished ROS generation during both ischemic and reperfusion phases, and increased NO production and Akt phosphorylation. Reperfusion treatment reduced the ROS burst in the early reperfusion phase only, and had no effect on NO production and Akt activation. Further, the phosphorylation of phosphatase and tensin homolog (PTEN), a phosphatase negatively regulating Akt activation, was significantly increased by baicalein preventive treatment and slightly by the I/R treatment. PTEN protein expression was reduced in the same trend accordingly. Baicalein reperfusion treatment had no effects on PTEN phosphorylation and expression. Our results indicate that baicalein preventive treatment confers optimal cardioprotection against I/R injury, and this protection involves effective oxidant scavenging and the activation of PTEN/Akt/NO pathway.

AB - Baicalein is a flavonoid with excellent oxidant scavenging capability. It has been reported to protect against a variety of oxidative injuries including ischemia/reperfusion (I/R). However, the optimal treatment strategy for I/R injury and the protective mechanisms are not fully understood. In this study we employed an established chick cardiomyocyte model of I/R and investigated the effects of three baicalein treatment strategies on reactive oxygen species (ROS) scavenging, nitric oxide (NO) production and cell viability. The molecular signaling pathways were also explored. Compared to the I/R control (cell death 52.2±2.0%), baicalein preventive treatment (25μM, pretreated for 72h and continued through I/R) conferred the best protection (19.5±3.9%, p<0.001), followed by I/R treatment (treated during I/R) and reperfusion treatment (treated at reperfusion only). Preventive and I/R treatments almost completely abolished ROS generation during both ischemic and reperfusion phases, and increased NO production and Akt phosphorylation. Reperfusion treatment reduced the ROS burst in the early reperfusion phase only, and had no effect on NO production and Akt activation. Further, the phosphorylation of phosphatase and tensin homolog (PTEN), a phosphatase negatively regulating Akt activation, was significantly increased by baicalein preventive treatment and slightly by the I/R treatment. PTEN protein expression was reduced in the same trend accordingly. Baicalein reperfusion treatment had no effects on PTEN phosphorylation and expression. Our results indicate that baicalein preventive treatment confers optimal cardioprotection against I/R injury, and this protection involves effective oxidant scavenging and the activation of PTEN/Akt/NO pathway.

KW - Akt

KW - Baicalein

KW - Cardiomyocyte

KW - Ischemia/Reperfusion

KW - Nitric Oxide

KW - PTEN

KW - Reactive Oxygen Species

UR - http://www.scopus.com/inward/record.url?scp=85026520529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026520529&partnerID=8YFLogxK

U2 - 10.1142/S0192415X17500525

DO - 10.1142/S0192415X17500525

M3 - Article

C2 - 28760044

AN - SCOPUS:85026520529

VL - 45

SP - 987

EP - 1001

JO - American Journal of Chinese Medicine

JF - American Journal of Chinese Medicine

SN - 0192-415X

IS - 5

ER -